Evidence map›Paper›PMID 36611919›Full record

ArticleCells2022

SR Protein Kinase 1 Inhibition by TAF15.

Anastasia Koukiali, Makrina Daniilidou, Ilias Mylonis, Thomas Giannakouros, Eleni Nikolakaki

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. MCellular oncology (Dordrecht, Netherlands) · 2026
    Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Anastasia KoukialiLaboratory of Biochemistry, Department of Chemistry, Aristotle University, 54124 Thessaloniki, Greece.ORCID 0000-0002-5058-8442
Makrina DaniilidouLaboratory of Biochemistry, Department of Chemistry, Aristotle University, 54124 Thessaloniki, Greece.ORCID 0000-0002-5460-9802
Ilias MylonisLaboratory of Biochemistry, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece.ORCID 0000-0002-0893-6618
Thomas GiannakourosLaboratory of Biochemistry, Department of Chemistry, Aristotle University, 54124 Thessaloniki, Greece.ORCID 0000-0001-7347-407X
Eleni NikolakakiLaboratory of Biochemistry, Department of Chemistry, Aristotle University, 54124 Thessaloniki, Greece.ORCID 0000-0003-3388-3850
Aristotle University of Thessaloniki · GRUniversity of Thessaly · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although SRPKs were discovered nearly 30 years ago, our understanding of their mode of regulation is still limited. Regarded as constitutively active enzymes known to participate in diverse biological processes, their prominent mode of regulation mainly depends on their intracellular localization. Molecular chaperones associate with a large internal spacer sequence that separates the bipartite kinase catalytic core and modulates the kinases' partitioning between the cytoplasm and nucleus. Besides molecular chaperones that function as anchoring proteins, a few other proteins were shown to interact directly with SRPK1, the most-studied member of SRPKs, and alter its activity. In this study, we identified TAF15, which has been involved in transcription initiation, splicing, DNA repair, and RNA maturation, as a novel SRPK1-interacting protein. The C-terminal RGG domain of TAF15 was able to associate with SRPK1 and downregulate its activity. Furthermore, overexpression of this domain partially relocalized SRPK1 to the nucleus and resulted in hypophosphorylation of SR proteins, inhibition of splicing of a reporter minigene, and inhibition of Lamin B receptor phosphorylation. We further demonstrated that peptides comprising the RGG repeats of nucleolin, HNRPU, and HNRNPA2B1, were also able to inhibit SRPK1 activity, suggesting that negative regulation of SRPK1 activity might be a key biochemical property of RGG motif-containing proteins.

Indexed as

Protein Serine-Threonine KinasesRNA SplicingCell NucleusMolecular ChaperonesPhosphorylationMolecular ChaperonesProtein Serine-Threonine KinasesHNRNPA2B1HNRNPULBRnucleolinRGG motifSRPK1SR proteinsTAF15

Identifiers

PMID36611919
PMCPMC9818988
OpenAlexW4313414584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.